Literature DB >> 10795627

Role of the cytoskeletal protein paxillin in oncogenesis.

M Sattler1, E Pisick, P T Morrison, R Salgia.   

Abstract

The focal adhesion is an important cellular structure that is involved in cell signaling, cell motility, and oncogenic transformation. Paxillin is a unique adapter protein that is localized to the focal adhesion and is involved in regulating various functions of the focal adhesion. The predicted amino acid structure for paxillin shows at the amino-terminus five LD motifs, a proline-rich domain, several potential phosphorylation sites and four carboxy-terminal LIM domains. Paxillin interacts with cell surface receptors and the actin cytoskeleton and activates several signal transduction pathways that are known to regulate normal cell physiology. Because paxillin is a central protein within the focal adhesion, it is a common target of many different oncoproteins, such as BCR/ABL, v-Src, and E6. In this review we summarize the current knowledge about the structure/function of paxillin and its family members, its role in integrin, cytokine signaling, and oncogenic transformation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10795627

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  22 in total

1.  Loss of the EP2 prostaglandin E2 receptor in immortalized human keratinocytes results in increased invasiveness and decreased paxillin expression.

Authors:  Raymond L Konger; Glynis A Scott; Yvonne Landt; Jack H Ladenson; Alice P Pentland
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  The p21-activated kinase, PAK2, is important in the activation of numerous pancreatic acinar cell signaling cascades and in the onset of early pancreatitis events.

Authors:  Bernardo Nuche-Berenguer; Irene Ramos-Álvarez; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2016-02-18

3.  MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells.

Authors:  Jun Qin; Feiran Wang; Haiyan Jiang; Junfei Xu; Yasu Jiang; Zhiwei Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  Interaction of zyxin, a focal adhesion protein, with the e6 protein from human papillomavirus type 6 results in its nuclear translocation.

Authors:  Y Y Degenhardt; S Silverstein
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma.

Authors:  Hai-Gang Li; De-Rong Xie; Xi-Ming Shen; Hong-Hao Li; Hong Zeng; Yun-Jie Zeng
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

6.  Group II p21-activated kinase, PAK4, is needed for activation of focal adhesion kinases, MAPK, GSK3, and β-catenin in rat pancreatic acinar cells.

Authors:  Irene Ramos-Álvarez; Lingaku Lee; Robert T Jensen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-27       Impact factor: 4.052

7.  Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling.

Authors:  Xiongzhi Wangpu; Jiaoyang Lu; Ruxing Xi; Fei Yue; Sumit Sahni; Kyung Chan Park; Sharleen Menezes; Michael L H Huang; Minhua Zheng; Zaklina Kovacevic; Des R Richardson
Journal:  Mol Pharmacol       Date:  2016-02-19       Impact factor: 4.436

8.  Structural features of the focal adhesion kinase-paxillin complex give insight into the dynamics of focal adhesion assembly.

Authors:  Craig M Bertolucci; Cristina D Guibao; Jie Zheng
Journal:  Protein Sci       Date:  2005-02-02       Impact factor: 6.725

9.  Role of c-Met in cancer: emphasis on lung cancer.

Authors:  Ravi Salgia
Journal:  Semin Oncol       Date:  2009-04       Impact factor: 4.929

10.  Expression and functional studies of ubiquitin C-terminal hydrolase L1 regulated genes.

Authors:  Anjali Bheda; Julia Shackelford; Joseph S Pagano
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.